<?xml version="1.0" encoding="UTF-8" ?>
<?xml-stylesheet type="text/xsl" href="http://articles.mercola.com/utility/FeedStylesheets/rss.xsl" media="screen"?><rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:slash="http://purl.org/rss/1.0/modules/slash/" xmlns:wfw="http://wellformedweb.org/CommentAPI/"><channel><title>More Aspirin Controversy</title><link>http://articles.mercola.com/sites/articles/archive/2000/10/29/aspirin-part-three.aspx</link><description>Several recent reports have called into question the benefits of daily aspirin use (see links below) in the prevention of cardiovascular disease. Now comes new questions about aspirin's effectiveness at preventing thromboembolism. In April, a large randomized</description><dc:language>en</dc:language><generator>CommunityServer 2008.5 SP1 (Build: 31106.3070)</generator></channel></rss>